Unlike prices, regulatory policy requires articulated justifications and objective standards.
Varying reasons lay behind the results, including falling oil prices, regulatory issues and a slowdown in China, although some big businesses are still performing well, notably Apple, the biggest of them all.
For example, the boards of financial institutions, power companies, and other organizations with complex market, credit, liquidity, commodity pricing, regulatory and other risks that require special attention may find a risk committee useful.
The broker said: Admiral's business model is highly geared to growth yet the first half demonstrated how the company is coming under increasing pressure from softer UK insurance pricing, regulatory change and most importantly in our view, a decision to rein in volume growth.
Doctoral students are exposed to state-of-the-art treatments of a variety of current issues in real estate, including structured financing, contract design and pricing, regulatory issues in real estate finance, real estate cycles, real options, agglomeration economies and the structure and operation of mortgage, housing and land markets.
And it casts a spotlight on the problems drug companies now face: a drought of big drug breakthroughs and research discoveries; pressure from insurers and the government to hold down prices; regulatory vigilance and government investigations; and thousands of layoffs in research and development.
Sixty-one billion dollars of subsidies and impossible-to-price regulatory preferences later, it's still the most expensive source of conventional energy on the grid.
These concerns underscore the need for a range of complementary non-price regulatory and educational measures to outlaw the promotion of tobacco products and to educate smokers about the risks of smoking and medicinal aids and behavioural tips to improve success rates in quitting.
In the European Union (EU), cost-containment measures include external and internal reference pricing, regulatory steering of market access, public tendering, price freezes, cuts and discounts, regulation of profit margins for pharmacists and wholesalers, patient cost-sharing, guidelines for and monitoring of prescribing behaviours, and generic substitution [ 4, 5].
Price and regulatory approval will be the biggest hurdles to reaching a deal, bankers and analysts said.
